Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Organogenesis Holdings Inc has a consensus price target of $7.25 based on the ratings of 4 analysts. The high is $9 issued by BTIG on December 26, 2025. The low is $5 issued by Lake Street on June 28, 2024. The 3 most-recent analyst ratings were released by BTIG on December 26, 2025, December 15, 2025, and November 20, 2025, respectively. With an average price target of $9 between BTIG, there's an implied 126.70% upside for Organogenesis Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 12/26/2025 | Buy Now | 126.7% | BTIG | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 12/15/2025 | Buy Now | 126.7% | BTIG | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 11/20/2025 | Buy Now | 126.7% | BTIG | $7 → $9 | Maintains | Buy | Get Alert |
| 09/26/2025 | Buy Now | 76.32% | BTIG | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2025 | Buy Now | 126.7% | Cantor Fitzgerald | $7 → $9 | Maintains | Overweight | Get Alert |
| 07/15/2025 | Buy Now | 76.32% | Cantor Fitzgerald | $7 → $7 | Reiterates | Overweight → Overweight | Get Alert |
| 03/05/2025 | Buy Now | 51.13% | Morgan Stanley | $4 → $6 | Maintains | Equal-Weight | Get Alert |
| 06/28/2024 | Buy Now | 25.94% | Lake Street | → $5 | Initiates | → Buy | Get Alert |
| 03/01/2024 | Buy Now | 25.94% | Cantor Fitzgerald | $5 → $5 | Reiterates | Overweight → Overweight | Get Alert |
| 02/07/2024 | Buy Now | 25.94% | Cantor Fitzgerald | → $5 | Initiates | → Overweight | Get Alert |
| 12/27/2023 | Buy Now | 51.13% | BTIG | $4 → $6 | Maintains | Buy | Get Alert |
| 11/14/2023 | Buy Now | -11.84% | Morgan Stanley | $3 → $3.5 | Maintains | Equal-Weight | Get Alert |
| 08/11/2023 | Buy Now | -24.43% | Morgan Stanley | $5 → $3 | Maintains | Equal-Weight | Get Alert |
| 08/10/2023 | Buy Now | 0.76% | BTIG | $10 → $4 | Maintains | Buy | Get Alert |
| 06/15/2023 | Buy Now | 25.94% | Morgan Stanley | → $5 | Initiates | → Equal-Weight | Get Alert |
| 05/24/2023 | Buy Now | 151.89% | BTIG | → $10 | Upgrade | Neutral → Buy | Get Alert |
The latest price target for Organogenesis Holdings (NASDAQ:ORGO) was reported by BTIG on December 26, 2025. The analyst firm set a price target for $9.00 expecting ORGO to rise to within 12 months (a possible 126.70% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Organogenesis Holdings (NASDAQ:ORGO) was provided by BTIG, and Organogenesis Holdings reiterated their buy rating.
The last upgrade for Organogenesis Holdings Inc happened on May 24, 2023 when BTIG raised their price target to $10. BTIG previously had a neutral for Organogenesis Holdings Inc.
There is no last downgrade for Organogenesis Holdings.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Organogenesis Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Organogenesis Holdings was filed on December 26, 2025 so you should expect the next rating to be made available sometime around December 26, 2026.
While ratings are subjective and will change, the latest Organogenesis Holdings (ORGO) rating was a reiterated with a price target of $9.00 to $9.00. The current price Organogenesis Holdings (ORGO) is trading at is $3.97, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.